Harvest Investment Services Dumps: What It Means for Investors
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...
Which Is Better Price Weighted Or Cap Weighted Index
Choosing between price and cap weighting depends on your objectives and risk tolerance. This guide highlights strengths and trade-offs.
26,659 articlesMicron Just Ripped 93% in a Month: Time to Cash Out?
Micron Technology has surged 93% in the last month on AI data center demand. Investors weigh whether to lock in gains...
Iran Emerges From with War: Economy Free Fall Deepens
Iran faces a sharp economic decline after renewed conflict, with staple prices surging and millions at risk of povert...
10-Year SpaceX Investor Says Valuation Is Too Cheap
A veteran SpaceX backer contends the $2 trillion IPO valuation understates the long-term growth in space infrastructu...
Occidental Petroleum Jumps While Oil Surges Across Markets
Occidental Petroleum climbs on an Evercore upgrade and a stronger oil backdrop, outpacing ExxonMobil and Chevron as t...
Ethereum Foundation Starts Staking: Treasury Moves
The Ethereum Foundation has begun staking ETH as part of a new treasury plan, coinciding with sales from Ethereum co-...
Exclusive: NYSE Parent Company Bets on OKX at $25B
Intercontinental Exchange, the parent company of the NYSE, is investing in OKX at a $25 billion valuation and will jo...
Intel Rallies Chip Launch to Signal Turnaround Hope
Intel stock jumped about 8% after the company unveiled Core Ultra Series 3 enterprise processors on the 18A node and ...
Rivian Faces Biggest Short-Term Threat: What Investors Need to Know
Rivian has captured imaginations—and capital. But the next 12 months will test its ability to scale, control costs, a...
ETHA’s Spot Ethereum Promise Faces Staking Yield Gap Risk
ETHA’s Spot Ethereum Promise meets a built-in constraint: the iShares Ethereum Trust cannot pass through staking rewa...
This Stock Already Won: AI Winners the Market Missed
In a market obsessed with the next AI breakthrough, one stock stands out not for hype but for real, lasting traction....
AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status